E-LIB Suche - Ergebnisse für: Dane, Aaron

1

System-wide approaches to antimicrobial therapy and antimic..:

Abel, Kathryn ; Agnew, Emily ; Amos, James...
The Lancet Microbe. 5 (2024) 5 - p. e500-e507 , 2024

2

Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours..:

Mangino, Julie E. ; Firstenberg, Michael S. ; Milewski, Rita K.C....
Infection Control & Hospital Epidemiology. 44 (2023) 7 - p. 1171-1173 , 2023

Link: https://doi.org/10.1017/..

3

Food and Drug Administration Public Workshop Summary—Develo..:

Yasinskaya, Yuliya ; Bala, Shukal ; Waack, Ursula...
Clinical Infectious Diseases. 77 (2023) 3 - p. 380-387 , 2023

Link: https://doi.org/10.1093/..

4

An obituary on DAV-132—authors' viewpoint on the current li..:

Vehreschild, Maria J G T ; Biehl, Lena M ; Dane, Aaron...
Journal of Antimicrobial Chemotherapy. 78 (2023) 6 - p. 1551-1553 , 2023

Link: https://doi.org/10.1093/..

5

754. Olorofim for treatment of invasive fungal infections (..:

Maertens, Johan A ; Thompson, George R ; Spec, Andrej...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

6

An open randomized multicentre Phase 2 trial to assess the ..:

Vehreschild, Maria J. G. T. ; Ducher, Annie ; Louie, Thomas...
Journal of Antimicrobial Chemotherapy. 77 (2022) 4 - p. 1155-1165 , 2022

Link: https://doi.org/10.1093/..

7

222. Clinical and microbiological outcomes for Enterobacter..:

Critchley, Ian A ; Critchley, Ian A ; Eckburg, Paul B...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

8

The Value of the Information That Can Be Generated: Optimiz..:

Dane, Aaron ; Rex, John H ; Newell, Paul.
Open Forum Infectious Diseases. 9 (2022) 7 - p. , 2022

Link: https://doi.org/10.1093/..

9

731. CERTAIN-1: A Phase 3 Study of Cefepime-Taniborbactam E..:

McGovern, Paul C ; Wagenlehner, Florian ; Gasink, Leanne...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

10

870. Olorofim for the treatment of invasive mould infection..:

Maertens, Johan A ; Verweij, Paul E ; Lanuza, Evan F...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

11

First-in-Human Evaluation of the Safety, Tolerability, and ..:

Talley, Angela K. ; Thurston, Archie ; Moore, Grayson...
Antimicrobial Agents and Chemotherapy. 65 (2021) 11 - p. , 2021

Link: https://doi.org/10.1128/..

12

Data-Driven and Confirmatory Subgroup Analysis in Clinical ..:

, In: Emerging Topics in Statistics and Biostatistics; Design and Analysis of Subgroups with Biopharmaceutical Applications,

Dmitrienko, Alex ; Lipkovich, Ilya ; Dane, Aaron. - p. 33-91 , 2020

Link: https://doi.org/10.1007/..

13

LB-5. DAV132 Protects Intestinal Microbiota of Patients Tre..:

Ducher, Annie ; Vehreschild, Maria J G T ; Vehreschild, Maria J G T...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S845-S846 , 2020

Link: https://doi.org/10.1093/..

14

LB-3. Oral Tebipenem Pivoxil Hydrobromide is Non-inferior t..:

Muir, Lori A ; Walpole, Susannah M ; Warfel, Patricia A...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S844-S845 , 2020

Link: https://doi.org/10.1093/..

15

1288. Phase 1 First-in-Human Single- and Multiple-Ascending..:

Talley, Angela ; Thurston Jr, Archie ; Moore, Grayson...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S659-S659 , 2020

Link: https://doi.org/10.1093/..